Lotte Biologics invests in S.Korean bio-venture Pinotbio
The two firms to collaborate in the development and production of ADC platform technology
By Apr 21, 2023 (Gmt+09:00)
Macquarie eyes its 1st Korean data center valued around $722 mn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
POSCO gears up for carbon-free steelmaking with hydrogen
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![Lotte Biologics invests in S.Korean bio-venture Pinotbio](https://www.kedglobal.com/data/ked/image/2023/04/21/ked202304210047.700x.0.jpg)
South Korea’s Lotte Biologics Co. said on Friday that it has made an equity investment in Pinotbio, Inc. for the development of antibody-drug conjugate (ADC) platforms.
Pinotbio possesses the necessary drugs and linker technology for the development of ADC anti-cancer agents.
Through this investment, Lotte Biologics plans to establish a strategic business partnership with PinotBio and collaborate in the development and production of ADC platform technology. The companies also plan to explore ADC contract development service partnerships.
Furthermore, the investment marks the beginning of Lotte Biologics' Bio-Venture Initiative. The company aims to provide facilities and technology development cooperation opportunities for biotechnology ventures in the antibody pharmaceutical production factory that they plan to build domestically.
"Through cooperation with PinotBio, we plan to accelerate the expansion of our ADC CDMO business," said Lee, Won-Jik, the CEO of Lotte Biologics.
Write to Ji-Hyun Lee at bluesky@hankyung.com
-
Bio & PharmaLotte Biologics to invest additional $48 mn in US plant
Apr 18, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaLotte Biologics, Excellgene to collaborate on CDO biz
Apr 03, 2023 (Gmt+09:00)
1 Min read